Checked
biote Corp.
Nasdaq: BTMD · Medicinal Chemicals & Botanical Products · Irving, TX
- Revenue
- $192.2M
- -2.5% vs. prior year
- Net income
- $27.05M
- 14.1% net margin
- Total assets
- $107.6M
- Diluted EPS
- $0.74
Company details
As reported to the SEC
- SEC CIK
- 1819253
- Stock
- Nasdaq: BTMD
- Industry (SIC)
- Medicinal Chemicals & Botanical Products (2833)
- Headquarters
- 1875 W. Walnut Hill Ln #100, Irving, TX 75038
- Fiscal year end (SEC record)
- December 31
- Filer status
- Accelerated filer, Smaller reporting company, Emerging growth company
- Phone
- (972) 486-9346
- Employer ID (EIN)
- 85-1791125
- Last annual report
- 03/13/2026
- Last quarterly report
- 08/07/2026
Formerly: Haymaker Acquisition Corp. III (until 05/25/2022)
Annual financials
U.S. dollars, as tagged in each annual report's XBRL data. Later restatements replace earlier numbers. Select a date to open the filing.
| Fiscal year ended | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 |
|---|---|---|---|---|---|
| Revenue | $192.2M | $197.2M | $185.4M | $165M | $139.4M |
| Operating income | $35.55M | $31.61M | $28.66M | -$60.72M | $34.56M |
| Net income | $27.05M | $3.16M | $3.32M | -$969K | $11.11M |
| Diluted earnings per share | $0.74 | $0.09 | $0.13 | -$0.12 | Not reported |
| Total assets | $107.6M | $122.4M | $155.3M | $111.6M | $54.33M |
| Total liabilities | $158M | $224.6M | $191.8M | $169.9M | $50.2M |
| Shareholders' equity | -$58.54M | -$105.9M | -$29.4M | -$44.46M | $4.13M |
| Cash and cash equivalents | $24.12M | $39.34M | $89M | $79.23M | $130.4K |
| Long-term debt | $95.78M | $101.2M | $106.6M | $112.1M | $31.96M |
| Cash from operations | $35.19M | $45.24M | $26.88M | -$9.16M | $33.72M |
| Capital expenditures | $5.01M | $6.43M | $359K | $333K | $1.45M |
Recent filings
103 recent filings on record; insider ownership forms (3, 4, 5 and 144) are not listed here
Swipe the table sideways to see more columns.
14 insider ownership reports (Forms 3, 4, 5 and 144) were filed about biote Corp. in the last 12 months. They list trades by officers, directors and large holders; see them on SEC EDGAR.
Other medicinal chemicals & botanical products
Swipe the table sideways to see more columns.
| Company | Headquarters | Revenue | Net income |
|---|---|---|---|
| Curaleaf Holdings, Inc.CURLF | Stamford, CT | $1.27B | -$231.1M |
| Trulieve Cannabis Corp.TRLV | Tallahassee, FL | $1.18B | -$122.2M |
| Usana Health Sciences IncUSNA | Salt Lake City, UT | $925.3M | $10.76M |
| Tilray Brands, Inc.TLRY | New York, NY | $915.5M | -$121.4M |
| Cresco Labs Inc.CRLBF | Chicago, IL | $655.8M | -$135.4M |
| Ascend Wellness Holdings, Inc.AAWH | Rochelle Park, NJ | $500.6M | -$118.2M |
| Jushi Holdings Inc.JUSH | Boca Raton, FL | $262.9M | -$68.59M |
| Glass House Brands Inc.GLAS | Long Beach, CA | $182M | -$29.66M |
Profile refreshed Oct 26, 2026; financials refreshed Oct 22, 2026.
Frequently asked questions
- What is biote Corp.'s CIK number?
- biote Corp.'s SEC Central Index Key (CIK) is 1819253.
- What is biote Corp.'s stock ticker?
- biote Corp. trades as Nasdaq: BTMD.
- What was biote Corp.'s revenue?
- biote Corp. reported revenue of $192.2M for the fiscal year ended Dec 31, 2025, -2.5% from the year before.
- When does biote Corp.'s fiscal year end?
- biote Corp.'s fiscal year end on file with the SEC is December 31; its most recent fiscal year ended Dec 31, 2025.
- Where is biote Corp. headquartered?
- biote Corp.'s principal executive office on file with the SEC is in Irving, TX.
Source: U.S. Securities and Exchange Commission, EDGAR submissions and XBRL company facts · Last updated 10/26/2026